🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on the fourteenth of October at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our family has dimmed his light for us in this life,” his family stated. “After a lengthy and brave struggle with cancer, we are heartbroken to declare that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and partnerships with renowned musicians.

He released his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The record reached the fourth spot on the R&B charts, went platinum later that year, and earned multiple award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his artistic journey into the stratosphere. The album premiered at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal showed the singer, notably stripped down to his midsection, performing straight into the camera.

D’Angelo retreated from the public eye after putting out Voodoo and openly battled with substance abuse. In 2005, he was involved in a serious car crash that left him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with another No. 1 debut on the soul music rankings and a Grammy for Best R&B Album.

Again, in his own mysterious way, D’Angelo had limited public outings in the subsequent period.

The musician was scheduled as a top act for the 2025 music event, but his performance was canceled, due to an “unexpected health issue.”

Although details are sparse about D’Angelo’s health in the weeks leading up to his death, he had reportedly been hospitalized for months and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable types of the illness, on a gifted artist whose life was cut short.

“We are saddened that he can only leave dear memories with his family, but we are eternally grateful for the legacy of extraordinarily moving songs he leaves behind,” his family expressed.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic cancer affects the digestive organ, a small organ that generates the hormone insulin and is vital in digestion, among additional roles. The position and dimensions of the organ in the body make it more difficult to identify cancer.

Although this cancer accounts for only about 3% of malignancy cases annually in the U.S., it is causes seven percent of cancer deaths.

Almost 70,000 people will be diagnosed with pancreatic cancer and about fifty-two thousand will succumb to the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have limited and poor therapies, and a smaller window to make a significant difference on the lives of patients,” noted a cancer specialist.

Because pancreatic cancer seldom produces initial signs, it’s frequently identified only after the disease is advanced. Even when a patient has indicators they are usually vague and may be confused with a number of common illnesses.

“As of yet, there is no effective method to identify pancreatic cancer in the initial phases, except for listening to your body and speaking with your doctor if there are new or unusual symptoms,” said a medical director.

Frequent indicators of this disease encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• brownish urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five range. However, numerous malignancies, such as pancreatic cancer, have become more common in younger adults.

“This disease identified prior to fifty is deemed uncommon, yet alarmingly, doctors are noticing a growing number of younger individuals affected by this condition,” said a specialist.

Family History Impacts Disease Probability

In the absence of reliable screening tools for this malignancy, professionals stressed the significance of understanding your relatives’ cancer history. Some risk factors, such as tobacco use and excess weight also play a role in the development of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the U.S. and are more prone to be found to have inoperable cancer.

“The first step toward lowering one’s risk of this condition is understanding personal risk factors. People should review their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their susceptibility,” said a medical professional.

Hereditary elements are linked to as much as ten percent of all pancreatic cancer instances. If someone in your family has had pancreatic cancer, you may want to think about genetic testing.

“For individuals with a family history of pancreatic cancer or those carrying high risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the pancreas,” he clarified.

For those looking to reduce their risk, lifestyle changes may have an effect. The best action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreatitis, a risk factor for pancreatic cancer, so reducing or abstaining from drinks may assist lower your chance.

Controlling your weight or losing weight may also help reduce your risk. Individuals with excess weight are 20% more likely to get this disease. This malignancy also is more frequent in people with blood sugar issues, and reducing weight can also reduce the chance of type 2 diabetes.

Despite this disease’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and more recent combination chemotherapy. There are emerging precision medicines that are already making an impact,” remarked a expert.

For numerous individuals, however, awareness about this uncommon but {dev